This inventor holds 1 USPTO granted patent. Top assignee: Acurastem, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ronghua Li and PIKfyve Kinase Inhibitor Innovation.
Introduction
Ronghua Li is an inventor associated with Pasadena, California, and Acurastem, Inc. His patent work concerns compounds that inhibit PIKfyve, an enzyme involved in cellular processes.
Latest Patents
Li is credited with 1 patent, titled “PIKfyve Kinase Inhibitors.” The invention describes compounds that inhibit phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) and their potential use in treating diseases and disorders associated with PIKfyve.
Career Highlights
The available information connects Li’s inventive work with Acurastem, Inc. His patent focuses on a therapeutic approach based on targeting PIKfyve.
Collaborations
Li’s listed coworkers include Martin Smrcina and Anil Nair. Their names provide context for the professional network associated with his work.
Conclusion
Ronghua Li’s patent on PIKfyve kinase inhibitors reflects an effort to develop compounds with potential applications in treating PIKfyve-associated conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile